Szlávik, M.; Haffarases, L.I.; Mandel, R.; Fekecs, F.; Apáti, Á.; Paczal, A.; Kotschy, A.; Szakács, G.; Tóth, S.
Imidazolinium-Based NHC–Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro. Int. J. Mol. Sci. 2025, 26, 11382.
https://doi.org/10.3390/ijms262311382
AMA Style
Szlávik M, Haffarases LI, Mandel R, Fekecs F, Apáti Á, Paczal A, Kotschy A, Szakács G, Tóth S.
Imidazolinium-Based NHC–Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro. International Journal of Molecular Sciences. 2025; 26(23):11382.
https://doi.org/10.3390/ijms262311382
Chicago/Turabian Style
Szlávik, Márton, Lidia Ines Haffarases, Réka Mandel, Fanni Fekecs, Ágota Apáti, Attila Paczal, András Kotschy, Gergely Szakács, and Szilárd Tóth.
2025. "Imidazolinium-Based NHC–Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro" International Journal of Molecular Sciences 26, no. 23: 11382.
https://doi.org/10.3390/ijms262311382
APA Style
Szlávik, M., Haffarases, L. I., Mandel, R., Fekecs, F., Apáti, Á., Paczal, A., Kotschy, A., Szakács, G., & Tóth, S.
(2025). Imidazolinium-Based NHC–Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro. International Journal of Molecular Sciences, 26(23), 11382.
https://doi.org/10.3390/ijms262311382
